SCYNEXIS, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
SCYNEXIS, Inc. (SCYX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $71.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-28.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2024-03-28
- SCYNEXIS, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-12-31 was $0.00.
- SCYNEXIS, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-09-30 was $0.00.
- SCYNEXIS, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- SCYNEXIS, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-03-31 was $71.00K.
- SCYNEXIS, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $71.00K, a 90.73% decline from fiscal 2021.
- SCYNEXIS, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $766.00K.
- SCYNEXIS, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2016 was $244.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $71.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $71.00K 10-Q · filed 2023-11-13 | $71.00K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $71.00K 10-Q · filed 2023-08-14 | $71.00K derived: sum of 3 quarters · filed 2023-08-14 | $71.00K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $71.00K 10-Q · filed 2023-05-10 | $71.00K derived: sum of 2 quarters · filed 2023-05-10 | $71.00K derived: sum of 3 quarters · filed 2023-05-10 | $837.00K derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $766.00K derived: sum of 3 quarters · filed 2023-03-31 | $766.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $766.00K derived: sum of 2 quarters · filed 2022-11-09 | $766.00K 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $766.00K 10-Q · filed 2022-08-15 | $766.00K 10-Q · filed 2022-08-15 | |||
| 2021-05-13 | $500.00K 10-K · filed 2023-03-31 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $244.00K 10-K · filed 2018-03-13 | |||
| 2016-09-30 | $244.00K 10-Q · filed 2016-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |